# Ernexa Therapeutics Inc.: Form S-1/A, filed Nov 23, 2021

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: S-1/A
- Filed: 2021-11-23
- Accepted by EDGAR: Nov 23, 2021, 06:06 ET
- Period: not reported
- Accession: 0001140361-21-039018
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036121039018/ny20001244x3_s1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036121039018/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036121039018/ny20001244x3_s1a.htm

Filed Nov 23, 2021.
Source: SEC EDGAR, the filing index for accession 0001140361-21-039018. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
